Dual-energy CT for differentiation of hypodense liver lesions in pancreatic adenocarcinoma.

Objective: To assess the accuracy of CT spectral HU curve assessment of hypodense liver lesions.

Methods: In this retrospective HIPAA-compliant study (January 2016 through May 2023), patients with biopsy-proven pancreatic adenocarcinoma and a biopsied indeterminate liver lesion underwent a DECT abdominal CT scan. Spectral HU curves were provided for each hypodense liver lesion, and slopes were calculated. Lesion Hounsfield units, iodine concentration and virtual enhancement were recorded. The Wilcoxon rank sum test was used to compare malignant and benign lesions. Optimal cutoff points were estimated using ROC curves and Youden's Index.

Results: Thirty-six patients (19 men, 17 women) with a mean age of 63 years ± 9 (standard deviation), a mean height of 170.9 cm ± 9.5, a mean weight of 69.8 kg ± 14.5, and a body mass index of 23.9 kg/m² ± 3.5. Reference standard assessment identified 92 liver lesions (50 metastases, 24 cysts, 13 abscesses, 3 regions of inflammation, 2 hemangiomas) with a mean size of 1.1 cm ± 0.5. The mean interval between the CT and liver lesion biopsy was 24 days. A diagnosis of benign versus malignant was determined based on optimal cutoffs: spectral curve slope of 1.36, iodine concentration of 6.47 (100 µg/cm³), and enhancement of 10.25. The receiver operating curves (ROC) for diagnosis using spectral curve slope, iodine concentration, and virtual enhancement resulted in an area under the curve (AUC) of 0.948, 0.946, and 0.937, respectively.

Conclusion: Spectral HU curves and iodine concentration of well-defined hypodense liver lesions are highly accurate in the diagnosis of benign versus malignant lesions.

Key points: Question Limited evidence exists for spectral imaging diagnosis of liver lesions-can DECT accurately differentiate between benign and metastatic hypodense liver lesions? Findings Ninety-two hypodense liver lesions evaluated using HU keV curve slope, iodine concentration, and virtual enhancement resulted in accurate benign versus metastatic differentiation. Clinical relevance Hypodense liver lesions are a challenging issue at staging, often requiring further imaging, follow-up, and/or biopsy. The additional information from multi-energy CT can be useful to differentiate between benign and malignant lesions, thereby reducing the need for costly additional evaluation.